Bain Capital injects up to $300 million in Cardurion Pharmaceuticals
Bain joins existing investors Takeda Pharmaceuticals and Polaris Partners in supporting the evolution of the cardiovascular biotechnology company.
27 October 2021•3 mins read
Bain joins existing investors Takeda Pharmaceuticals and Polaris Partners in supporting the evolution of the cardiovascular biotechnology company.
Kohlberg-backed Trinity acquires Verix to add pharma AI execution tools
10 hours ago · 2 mins read
Brenton Point-backed Landmark Funeral Group agrees majority investment in Funeral Excellence Group
11 hours ago · 1 min read
LLCP completes sale of Global Loan Agency Services to Oakley Capital
14 hours ago · 1 min read
Vinci Compass agrees deal for Latin American reinsurer AustralRe
15 hours ago · 2 mins read
TA-backed Diatech Pharmacogenetics acquires German thermal cycler maker SensoQuest
15 hours ago · 1 min read
Broadwing-backed Forte Technologies adds Illinois cybersecurity compliance firm BCSS
16 hours ago · 1 min read
HCAP Partners-backed Real Diagnostics adds saliva-based oral health testing firm SimplyTest
17 hours ago · 1 min read
